A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

Source:http://linkedlifedata.com/resource/pubmed/id/18612102

Blood 2008 Sep 15 112 6 2248-60

Download in:

View as

Triples

General Info

PMID
18612102